BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16352580)

  • 1. Quantification and reduction of cardiac dose in radical radiotherapy for oesophageal cancer.
    Cominos M; Mosleh-Shirazi MA; Tait D; Henrys A; Cornes P
    Br J Radiol; 2005 Dec; 78(936):1069-74. PubMed ID: 16352580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers.
    Mukherjee S; Aston D; Minett M; Brewster AE; Crosby TD
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):115-20. PubMed ID: 12801047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endoscopic ultrasound (EUS) in planning radiotherapy target volumes for oesophageal cancer.
    Thomas E; Crellin A; Harris K; Swift S; Montefiore DS
    Radiother Oncol; 2004 Nov; 73(2):149-51. PubMed ID: 15542161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
    Su J; Zhu S; Liu Z; Zhao Y; Song C
    Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.
    Bedford JL; Viviers L; Guzel Z; Childs PJ; Webb S; Tait DM
    Radiother Oncol; 2000 Nov; 57(2):183-93. PubMed ID: 11054522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy.
    Nguyen NP; Krafft SP; Vinh-Hung V; Vos P; Almeida F; Jang S; Ceizyk M; Desai A; Davis R; Hamilton R; Modarresifar H; Abraham D; Smith-Raymond L
    Radiother Oncol; 2011 Dec; 101(3):438-42. PubMed ID: 21908064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential effect of robust and simple IMRT approach for left-sided breast cancer on cardiac mortality.
    Lohr F; El-Haddad M; Dobler B; Grau R; Wertz HJ; Kraus-Tiefenbacher U; Steil V; Madyan YA; Wenz F
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):73-80. PubMed ID: 18973977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome.
    Milano MT; Jani AB; Farrey KJ; Rash C; Heimann R; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):354-61. PubMed ID: 16168830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer.
    Wu VW; Sham JS; Kwong DL
    Br J Radiol; 2004 Jul; 77(919):568-72. PubMed ID: 15238403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the optimal co-planar field arrangement for use in the boost phase of dose escalated conformal radiotherapy for localized prostate cancer.
    Khoo VS; Bedford JL; Webb S; Dearnaley DP
    Br J Radiol; 2001 Feb; 74(878):177-82. PubMed ID: 11718391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
    Everitt S; Schneider-Kolsky M; Yuen K; Budd R; Mac Manus M
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):168-77. PubMed ID: 18373810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.